Dg Health Allergy Relief Tablet, Film Coated
NDC Package 55910-241-46
Package Information
Dg Health Allergy Relief (levocetirizine dihydrochloride) tablets is adults 65 years of age and older•ask a doctoradults and children 12-64 years of age•take 1 tablet (5 mg) once daily in the evening•do not take more than 1 tablet (5 mg) in 24 hours•½ tablet (2.5 mg) once daily in the evening may be appropriate for less severe symptomschildren 6-11 years of age•take ½ tablet (2.5 mg) once daily in the evening•do not take more than ½ tablet (2.5 mg) in 24 hourschildren under 6 years of age•do not useconsumers with kidney disease•do not use. This formulation utilizes a tablet, film coated delivery system. Marketed by Dolgencorp, Llc, this product is identified by NDC 55910-241 and is authorized under FDA application ANDA211983.
Identification & Billing
- RxCUI: 855172 - levocetirizine dihydrochloride 5 MG Oral Tablet
- RxCUI: 855172 - levocetirizine dihydrochloride 5 MG 24 HR Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 55910 - Dolgencorp, Llc
- 55910-241 - Dg Health Allergy Relief
- 55910-241-46 - 10 BLISTER PACK in 1 CARTON / 1 TABLET, FILM COATED in 1 BLISTER PACK
- 55910-241 - Dg Health Allergy Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 55910-241-46 identifies a specific commercial package of 10 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack of Dg Health Allergy Relief, a human over the counter drug labeled by Dolgencorp, Llc. This tablet, film coated is formulated for oral use and contains levocetirizine dihydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dolgencorp, Llc on June 17, 2021. The current certification is valid through December 31, 2027.
How is this Dolgencorp, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 55910024146. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.